GGHTx Co-Founder Avi Kerendian Discusses Telehealth Partnership During COVID-19 Crisis


Co-Founders of GGHTx, Avi Kerendian and Dr. Arash Hakhamian, have started a GGHTx and Dentulu

alliance on combating global health disparities through a revolutionary, free telehealth platform!

GGHTx Co-Founder Avi Kerendian Plans for COVID-19

Program Director and Co-Founder of GGHTx,
Avi Kerendian, is on a mission. Avi Kerendian’s vision with GGHTx has been
simple: to help underserved people in the most disadvantaged areas of Latin
America and Uganda, through the the support of young professionals in the
health sector, who are destined to create sustainable change in these places.

Although the current situation with the COVID-19 pandemic has led
to a suspension of travel for the time being, the vision continues. For this
reason, the GGHTX program has partnered with Dentulu, which is a startup tech
specialist in everything related to telehealth and teledentistry.

Who is Dentulu Co-Founder Dr. Arash Hakhamian?

Who is Dr. Arash Hakhamian from the GGHTx nonprofit?Dr.
Arash Hakhamian is an important leader in GGHTx as he is the co-founder and
medical director specializing in dental and oral surgery.Dr. Arash is a
lecturer and passionate about helping others, and has extensive experience as a
volunteer. His participation
and leadership in establishing the GGHTx program has been invaluable, as GGHTx
has become a unique organization, exclusively for students or young
professionals in the health, in which volunteers can travel the world helping

Dr. Arash’s wish is that these amazing volunteer trips will soon
be back, transforming the world for both doctors and patients.

Who is GGHTx Co-Founder Avi Kerendian?

is the Co-Founder Avi Kerendian of the GGHTx program?
Kerendian, is a key player in the development of the GGHTx program, as he is
the co-founder, and currentprogram director of the global health nonprofit. He
holds a Biology degreemagna cum laude, and has experience working at the
Memorial Sloan Kettering Cancer Center (MSKCC), where he trained in multiple
research-related specialties involving glioblastoma and breast cancer. He also
has a tremendous passion for helping people, which has contributed to making
the program a worldwide success. Kerendian also speak several languages:
English, Hebrew, Persian and Spanish, all fluently.

GGHTx and Dentulu Partnership

Dr. Arash and Avi Kerendian have used their desire to help and
contribute toeffected communitiesto create an alliance with the creation of
Dentulu, a recognized telehealth company that specializes in teledentistry,
which is a company and industry that will revolutionize health care service for
these third world countries. With this partnership, GGHTx will be able to reach
the most remote places, and even have continuous monitoring of patients through
technological resources that are available to almost everyone such as email, a
mobile device, telephone or computer. In fact, studies have detected that a
wide range of chronic diseases can be treated and monitored remotely. For that
reason, “Gracias” Global Health Trips (GGHTx) will make Dentulu freely available
to the most vulnerable people in the world so that vulnerable patients can be
treated, through remote consultations
or diagnoses.This in itself will be an invaluable help to revolutionizing the
global health and telehealth delivery industry, especially for the nonprofit
sector. The short-term plan is to scale the platform that continues in supporting low-income
patients or people living in remote areas for free, as well as keep up with new
technological trends, as the world is rapidly moving to a digital landscape
that can no longer be ignored.

Contact Information for GGHTx and Avi Kerendian

more information on volunteering and partnerships, please contact Avi Kerendian,
Co-Founder and Program Director of GGHTx via email at,
visit the GGHTx website at

The post GGHTx Co-Founder Avi Kerendian Discusses Telehealth Partnership During COVID-19 Crisis appeared first on Living Gossip.


Leave a Reply

Your email address will not be published. Required fields are marked *